Similar Items: Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy
- Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
- Potential therapeutic targeting of BKCa channels in glioblastoma treatment
- Vitamin D should be considered as a targeted therapy in glioblastoma cases
- The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
- NKCC1: A key regulator of glioblastoma progression
- Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2